Horák Petr, Peppard Joan, Sýkora Juraj, Miharija Gala Tajda, Underhill Jonathan, Gibbons Nicholas
Department of Hospital Pharmacy, University Hospital Motol, Prague 5, Czech Republic.
Department of Pharmacy, Midland Regional Hospital, Tullamore, Ireland.
Eur J Hosp Pharm. 2016 Mar;23(2):69-75. doi: 10.1136/ejhpharm-2016-000889.
The European Statements baseline survey was designed to give an insight to how well the European Statements of Hospital Pharmacy (the Statements) are being implemented and to help inform the European Association of Hospital Pharmacists (EAHP) implementation strategy for the Statements.
The online questionnaire was sent to all hospital pharmacies in EAHP member countries. More than 1000 pharmacists completed the survey, which was analysed by Keele University and presented to EAHP.
The survey provided general data for each country about the staffing levels and skill mix within each hospital, how well each hospital was implementing each Statement and finally about what were the barriers to implementation for European hospital pharmacists. The survey identified that, generally, the sections covering more traditional roles of hospital pharmacists (procurement, compounding) were being well implemented-96% of respondents indicated that their hospitals had clear processes in place around the procurement of medicines; 91% indicated "When medicines require manufacture or compounding, we either produce them in our hospital pharmacy or we outsource to an approved provider". Compared with that, clinical pharmacy services, multidisciplinary approaches and active engagement in education and practice research activities are challenging areas in most EAHP member countries. In only 29% of hospitals, the pharmacists enter all medicines used onto the patient's medical record on admission. 49% of responders agreed that the pharmacists in their hospital routinely publish hospital pharmacy practice research. Insufficient capacity and capability in terms of staffing and resources seemed to be main reasons given for low implementation of some of the Statements.
After analysis of data from more than 1000 questionnaires, EAHP gained a necessary overview of Statements implementation level and barriers to implementation, needed for informed and efficient progress of EAHP implementation projects.
欧洲声明基线调查旨在深入了解《欧洲医院药学声明》（以下简称《声明》）的实施情况，并为欧洲医院药师协会（EAHP）制定《声明》的实施策略提供参考。
在线问卷被发送至EAHP成员国的所有医院药房。1000多名药师完成了该调查，由基尔大学进行分析并提交给EAHP。
该调查提供了每个国家关于各医院人员配备水平和技能组合的一般数据，各医院对每项声明的实施情况，以及欧洲医院药师实施过程中的障碍。调查发现，总体而言，涵盖医院药师更传统角色（采购、配制）的部分实施情况良好——96%的受访者表示，他们所在医院在药品采购方面有明确的流程；91%的受访者表示“当药品需要生产或配制时，我们要么在医院药房自行生产，要么外包给经批准的供应商”。相比之下，临床药学服务、多学科方法以及积极参与教育和实践研究活动在大多数EAHP成员国都是具有挑战性的领域。只有29%的医院，药师会在患者入院时将所用的所有药品录入病历。49%的受访者同意他们所在医院的药师会定期发表医院药学实践研究。人员配备和资源方面的能力不足似乎是一些声明实施率低的主要原因。
通过对1000多份问卷的数据进行分析，EAHP对声明的实施水平和实施障碍有了必要的总体了解，这对于EAHP实施项目的明智和高效推进是必要的。
